CLINICAL_TRIALS
trial_result
· 2019-02-06
Clinical Trial Update: Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease [Phase 2]
Summary
A Phase 2 clinical trial evaluated ixazomib citrate for chronic graft-versus-host disease; the study has completed and results were posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fred Hutchinson Cancer Center | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-02-06